What is the current drug data protection system in Argentina?

Patent period protection. According to Argentina's drug data protection system, when a drug manufacturer applies for a drug patent in Argentina, if the patent is approved, the innovative R&D personnel of the drug will be protected for a certain patent period from the date of approval, generally 20 years. During the patent period, other companies may not produce, sell or use the drug without authorization.